Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 21, 2018

View Archived Issues

Phase I trial explores cellular adoptive immunotherapy in sarcoma

ADAMTS18 found behind alveolar dysplasia and lung morphology

Nanotech-enabled mRNA delivery reactivates tumor suppressor

Vaspin shows cardioprotective effect in myocardial ischemia/reperfusion injury animal models

Treatment with the novel GPR88 agonist RTI-13951-33 reduces alcohol intake in vivo

QCA-570 demonstrates efficacy and safety in preclinical leukemia models

National Institute of Biomedical Innovation and Biken synthesize lipid A adjuvant

Pharming receives complete response letter from FDA for Ruconest

Hadasit Medical Research Services and Development, Ramot patent glycogen synthase inhibitors

Jiangsu Hansoh Pharmaceutical Group, Shanghai Hansoh Biomedical discover MAP3K5 inhibitors

Global phase III ALPS study of roxadustat meets primary endpoints

Hulio, a biosimilar to adalimumab, receives marketing authorization in Europe

IRLAB announces updates to its pipeline

PET tracer for renal imaging tested in vivo

First patient treated in phase I trial of BAY-1905254

First patient enrolled in phase IIa HIV study of GnRH agonist ISR-048

Further studies planned after first-in-human trial of respiratory disease candidate OATD-01

FDA accepts Cardurion's IND for phase I study of CRD-733

New OTC-deficient pig model of metabolic liver disease developed

Mesoblast reports survival outcomes through day 180 in phase III study of remestemcel-L

European Commission approves Braftovi with Mektovi for advanced melanoma with BRAFV600 mutation

Galectin Therapeutics reports preliminary phase Ib data on GR-MD-02 in advanced melanoma

Plasma NfL and CSF biomarkers for the diagnosis of AD in adults with Down syndrome

Lorlatinib receives first approval in Japan

Viruses use Treacle to make host cells more hospitable

Sihuan begins phase II study of benapenem

Cyp8b1 silencing improves nonalcoholic fatty liver disease in mice by remodeling the bile acid pool

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...